Accelerating Inhibitor Discovery for Multiple SARS-CoV-2 Targets with a Single, Sequence-Guided Deep Generative Framework

04/19/2022
by   Vijil Chenthamarakshan, et al.
14

The COVID-19 pandemic has highlighted the urgency for developing more efficient molecular discovery pathways. As exhaustive exploration of the vast chemical space is infeasible, discovering novel inhibitor molecules for emerging drug-target proteins is challenging, particularly for targets with unknown structure or ligands. We demonstrate the broad utility of a single deep generative framework toward discovering novel drug-like inhibitor molecules against two distinct SARS-CoV-2 targets – the main protease (Mpro) and the receptor binding domain (RBD) of the spike protein. To perform target-aware design, the framework employs a target sequence-conditioned sampling of novel molecules from a generative model. Micromolar-level in vitro inhibition was observed for two candidates (out of four synthesized) for each target. The most potent spike RBD inhibitor also emerged as a rare non-covalent antiviral with broad-spectrum activity against several SARS-CoV-2 variants in live virus neutralization assays. These results show that a broadly deployable machine intelligence framework can accelerate hit discovery across different emerging drug-targets.

READ FULL TEXT

page 1

page 3

research
04/02/2020

Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models

The recent COVID-19 pandemic has highlighted the need for rapid therapeu...
research
05/22/2020

Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics

De novo therapeutic design is challenged by a vast chemical repertoire a...
research
11/28/2022

Accelerating Antimicrobial Peptide Discovery with Latent Sequence-Structure Model

Antimicrobial peptide (AMP) is a promising therapy in the treatment of b...
research
11/28/2022

Reinforced Genetic Algorithm for Structure-based Drug Design

Structure-based drug design (SBDD) aims to discover drug candidates by f...
research
05/27/2020

PaccMann^RL on SARS-CoV-2: Designing antiviral candidates with conditional generative models

With the fast development of COVID-19 into a global pandemic, scientists...
research
05/27/2020

Targeted design of antiviral compounds against SARS-CoV-2 with conditional generative models

With the fast development of COVID-19 into a global pandemic, scientists...

Please sign up or login with your details

Forgot password? Click here to reset